Virta Health’s Nutrition Therapy Extends Survival by 34% in Stage IV Pancreatic Cancer Patients, New Clinical Trial Shows

DENVER, March 12, 2026–Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced pancreatic cancer is treated. Conducted in partnership with USC Norris Comprehensive Cancer Center, Mayo Clinic, HonorHealth Research Institute, and others, the study was peer-reviewed and published in Cancer, revealing that Virta’s medically supervised, individualized nutriti